Acer Therapeutics Inc. (DE) (ACER) Peer Comparison

$0.66

$-0.14 (-17.95%)

As on 20-Nov-2023 16:00EDT

Market cap

$16 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

17.3

Div. Yield

0 %

Edit

	Acer Therapeutics Inc. (DE) (ACER)	Miromatrix Medical Inc (MIRO)	Neoleukin Therapeutics (NLTX)	Seagen (SGEN)
Market cap ($ Mln)	16	93	8	43,155
Revenue ($ Mln)	0	1	--	2,300
Net Profit ($ Mln)	-60.92	-27.12	-39.36	-750.23
Net Margin (%)	1,778.97	-2,430.11	281,135.71	-32.61
RoE (%)	--	-125.15	-54.63	-28.45
Price to Earnings	--	--	--	--
Price-To-Book	17.26	5.98	0.44	16.92

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Acer Therapeutics Inc. (DE) (ACER)	Miromatrix Medical Inc (MIRO)	Neoleukin Therapeutics (NLTX)	Seagen (SGEN)
Operating Revenue	0.00	0.95	0.00	1,962.41
Cost of Revenue	--	0.50	--	410.06
Gross Profit	1.26	0.45	0.01	1,552.35
Operating Expenses	24.61	30.70	59.10	2,165.32
Operating Profit (EBIT)	-24.61	-30.25	-59.10	-612.97
Other Income	--	--	0.01	--
Profit before Tax	-26.24	-29.96	-57.56	-602.32
Provision for Tax	1.62	0.05	-1.54	7.99
Profit after Tax (Net Income)	-27.86	-30.01	-56.02	-610.31
Minority Interest	--	--	--	--
Consolidated Profit	-15.37	-14.67	-57.56	-610.31

Liabilities ($ Mln)

	Acer Therapeutics Inc. (DE) (ACER)	Miromatrix Medical Inc (MIRO)	Neoleukin Therapeutics (NLTX)	Seagen (SGEN)
Shareholder's Funds	-16.76	26.11	94.33	2,803.82
Minority Interest	--	--	--	--
Non-Current Liabilities	9.43	3.71	10.56	52.31
Current Liabilities	18.95	4.95	11.06	818.40
Total Liabilities	11.62	34.76	115.95	3,674.53

Assets ($ Mln)

	Acer Therapeutics Inc. (DE) (ACER)	Miromatrix Medical Inc (MIRO)	Neoleukin Therapeutics (NLTX)	Seagen (SGEN)
Non-Current Assets	8.11	7.45	16.81	1,939.46
Current Assets	3.52	27.31	99.13	1,735.07
Total Assets	11.62	34.76	115.95	3,674.53
Total Debt*	11.86	3.55	12.07	43.47
Net Current Assets	-15.44	22.36	88.07	1,984.13

Cashflow ($ Mln)

	Acer Therapeutics Inc. (DE) (ACER)	Miromatrix Medical Inc (MIRO)	Neoleukin Therapeutics (NLTX)	Seagen (SGEN)
Cash From Operating Activities	-30.25	-26.68	-45.61	-453.75
Cash Flow from Investing Activities	-0.05	-1.38	-59.13	228.24
Cash from Financing Activities	20.04	0.17	0.16	125.36
Net Cash Inflow / Outflow	--	--	-50.09	-100.15

Ratios

Profitability Ratios

	Acer Therapeutics Inc. (DE) (ACER)	Miromatrix Medical Inc (MIRO)	Neoleukin Therapeutics (NLTX)	Seagen (SGEN)
ROCE (%)	894.87	-70.93	-42.72	-20.45
ROE (%)	301.44	-74.80	-47.23	-20.80
ROA (%)	-116.37	-62.72	-40.13	-16.51
EBIT Margin (%)	--	--	--	--
Net Margin (%)	-1,168.94	-3,147.22	-486,791.67	-31.10
Cash Profit Margin (%)	--	--	--	--

Growth Ratios

	Acer Therapeutics Inc. (DE) (ACER)	Miromatrix Medical Inc (MIRO)	Neoleukin Therapeutics (NLTX)	Seagen (SGEN)
Revenue Growth (%)	-1.00	27.84	-1.00	0.25
EBIT Growth (%)	--	--	--	--
Net Profit Growth (%)	-89.16	-100.64	4.11	9.51
EPS Growth (%)	-0.66	-0.05	0.04	0.11
Book Value Growth (%)	--	--	--	--

Valuation Ratios

	Acer Therapeutics Inc. (DE) (ACER)	Miromatrix Medical Inc (MIRO)	Neoleukin Therapeutics (NLTX)	Seagen (SGEN)
Price / Earnings	-1.44	-2.09	-0.50	-39.18
Price / Book Value	-2.40	2.41	0.30	8.53
Dividend Yield (%)	--	--	--	--
EV/EBITDA	-2.00	-1.38	0.99	-35.64
Market Cap ($ Cr)	--	--	--	--

Solvency Ratios

	Acer Therapeutics Inc. (DE) (ACER)	Miromatrix Medical Inc (MIRO)	Neoleukin Therapeutics (NLTX)	Seagen (SGEN)
Debt to Equity	-0.71	0.14	0.13	0.02
Short term debt to equity ratio	-0.15	0.02	0.02	--
Current Ratio	0.19	5.52	8.96	2.12
Quick Ratio	0.93	5.36	--	1.60
Interest Coverage	-242.67	-633.66	-37.36	-5.92

Operating Efficiency Ratios

	Acer Therapeutics Inc. (DE) (ACER)	Miromatrix Medical Inc (MIRO)	Neoleukin Therapeutics (NLTX)	Seagen (SGEN)
Debtors to sales (%)	396.83	108.89	--	25.58
Asset Turnover	0.00	0.02	0.00	0.53
Receivable days	1,449.40	443.02	54,787.50	82.93
Inventory Days	--	584.47	--	279.63
Payable days	--	1,344.04	--	143.71
Cash Conversion Cycle	--	-316.54	--	218.86

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly